Analyst Ranking
Bottom 27%
#3594 out of 4882 analysts
Average Return
-0.05%
Win Rate
45%49 out of 109
Risk vs Reward
Poor
Good

Yatin Suneja's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Reata Pharmaceuticals IncRETA
+376.00%$36.21$172.36
2022-10-18 -
2023-09-25
Strong Buy
Vigil Neuroscience IncVIGL
+170.21%$2.92$7.89
2024-08-13 -
2025-05-23
Strong Buy
Longboard Pharmaceuticals IncLBPH
+138.96%$25.10$59.98
2024-01-01 -
2024-11-29
Strong Buy
Prometheus Biosciences IncRXDX
+102.65%$18.85$38.20
2021-04-05 -
2022-04-05
Strong Buy
Larimar Therapeutics IncLRMR
+101.36%$3.69$7.43
2023-05-16 -
2024-05-16
Strong Buy

Yatin Suneja's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cabaletta Bio IncCABA
5Strong Buy$25.00+1,328.57%Maintains
8 days ago
Gh Research PLCGHRS
1Strong Buy$29.00+159.62%Maintains
15 days ago
Argenx SeARGX
8Strong Buy$1,065.00+81.24%Maintains
15 days ago
Neurocrine Biosciences IncNBIX
5Strong Buy$165.00+37.29%Maintains
18 days ago
Anaptysbio IncANAB
8Strong Buy$54.00+164.19%Maintains
18 days ago
Phathom Pharmaceuticals IncPHAT
3Strong Buy$12.00+198.51%Maintains
22 days ago
Regeneron Pharmaceuticals IncREGN
6Strong Buy$810.00+37.68%Maintains
23 days ago
Zura Bio LtdZURA
2Strong Buy$15.00+1,370.59%Reiterates
2 months ago
Inflarx NvIFRX
3Strong Buy$10.00+440.54%Maintains
2 months ago
Larimar Therapeutics IncLRMR
4Strong Buy$26.00+1,290.37%Reiterates
2 months ago
Adicet Bio IncACET
1Strong Buy$7.00+908.65%Reiterates
2 months ago
Dianthus Therapeutics IncDNTH
1Strong Buy$84.00+355.90%Reiterates
2 months ago
Zenas Biopharma IncZBIO
2Strong Buy$45.00+293.70%Reiterates
2 months ago
Immunovant IncIMVT
4Strong Buy$44.00+204.29%Maintains
3 months ago
Surrozen IncSRZN
3Strong Buy$45.00+464.97%Upgrades
5 months ago
Acadia Pharmaceuticals IncACAD
6Hold$20.00-9.01%Downgrades
5 months ago
Spyre Therapeutics IncSYRE
1Strong Buy$65.00+333.04%Maintains
7 months ago
Vigil Neuroscience IncVIGL
2Strong Buy$16.00+102.79%Maintains
9 months ago
Praxis Precision Medicines IncPRAX
2Strong Buy$170.00+352.73%Maintains
9 months ago
Alumis IncALMS
1Strong Buy$32.00+556.41%Initiates Coverage On
10 months ago
Q32 Bio IncQTTB
1Strong Buy$100.00+6,072.84%Initiates Coverage On
a year ago
Abivax SaABVX
1Strong Buy$50.00N/AInitiates Coverage On
a year ago
Celldex Therapeutics IncCLDX
4Strong Buy$90.00N/AMaintains
a year ago
Axsome Therapeutics IncAXSM
7Strong Buy$125.00N/AMaintains
a year ago
Longboard Pharmaceuticals IncLBPH
3Strong Buy$32.00N/AMaintains
a year ago
Roivant Sciences LtdROIV
2Strong Buy$16.00N/AMaintains
2 years ago
Moonlake ImmunotherapeuticsMLTX
3Strong Buy$77.00N/AMaintains
2 years ago
Tourmaline Bio IncTRML
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Neumora Therapeutics IncNMRA
1Strong Buy$22.00N/AInitiates Coverage On
2 years ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$49.00N/AReiterates
2 years ago
Eyepoint Pharmaceuticals IncEYPT
2Strong Buy$55.00N/AMaintains
2 years ago
Bioxcel Therapeutics IncBTAI
2Strong Buy$736.00N/AMaintains
2 years ago
Biogen IncBIIB
3Strong Buy$350.00N/AUpgrades
2 years ago
Prometheus Biosciences IncRXDX
3Hold$200.00N/ADowngrades
2 years ago
Rapt Therapeutics IncRAPT
2Strong Buy$48.00N/AMaintains
2 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$116.50N/ADowngrades
2 years ago
Sage Therapeutics IncSAGE
3Strong Buy$48.00N/AMaintains
3 years ago
Reata Pharmaceuticals IncRETA
1Strong Buy$75.00N/AInitiates Coverage On
3 years ago
Relmada Therapeutics IncRLMD
3HoldN/AN/ADowngrades
3 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$330.00N/AMaintains
3 years ago
Bausch & Lomb CorpBLCO
1Strong Buy$24.00N/AInitiates Coverage On
3 years ago
Climb Bio IncCLYM
2HoldN/AN/ADowngrades
3 years ago
Seelos Therapeutics IncSEELQ
1Strong Buy$30,720.00N/AInitiates Coverage On
4 years ago
Global Blood Therapeutics IncGBT
1Strong BuyN/AN/AInitiates Coverage On
6 years ago
Seagen IncSGEN
1Strong Buy$80.00N/AUpgrades
7 years ago
Verona Pharma PLCVRNA
1Strong Buy$26.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.